These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 26001859

  • 1. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK, Beşbaş N, Topaloglu R, Ozen S.
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [Abstract] [Full Text] [Related]

  • 2. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O, Yildizgoren MT, Ilgen U, Ates A, Kinikli G, Turgay M, Erten S.
    Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
    [Abstract] [Full Text] [Related]

  • 3. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T, Aydın F, Nilüfer Tekgöz P, Sezer M, Uncu N, Çelikel Acar B.
    Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
    [Abstract] [Full Text] [Related]

  • 4. Interventions for reducing inflammation in familial Mediterranean fever.
    Yin X, Tian F, Wu B, Xu T.
    Cochrane Database Syst Rev; 2022 Mar 29; 3(3):CD010893. PubMed ID: 35349164
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever.
    Laskari K, Boura P, Dalekos GN, Garyfallos A, Karokis D, Pikazis D, Settas L, Skarantavos G, Tsitsami E, Sfikakis PP.
    J Rheumatol; 2017 Jan 29; 44(1):102-109. PubMed ID: 28042127
    [Abstract] [Full Text] [Related]

  • 7. Interventions for reducing inflammation in familial Mediterranean fever.
    Wu B, Xu T, Li Y, Yin X.
    Cochrane Database Syst Rev; 2018 Oct 19; 10(10):CD010893. PubMed ID: 30338514
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö, Kucuk H, Babaoglu H, Guven SC, Ozturk MA, Haznedaroglu S, Goker B, Tufan A.
    Mod Rheumatol; 2019 Mar 19; 29(2):363-366. PubMed ID: 29578360
    [Abstract] [Full Text] [Related]

  • 9. Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry.
    Sag E, Akal F, Atalay E, Akca UK, Demir S, Demirel D, Batu ED, Bilginer Y, Ozen S.
    Rheumatology (Oxford); 2020 Nov 01; 59(11):3324-3329. PubMed ID: 32306038
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.
    Babaoglu H, Varan O, Kucuk H, Atas N, Satis H, Salman R, Ozturk MA, Goker B, Tufan A, Haznedaroglu S.
    J Clin Rheumatol; 2020 Jan 01; 26(1):7-13. PubMed ID: 30048391
    [Abstract] [Full Text] [Related]

  • 11. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.
    Ozen S, Bilginer Y, Aktay Ayaz N, Calguneri M.
    J Rheumatol; 2011 Mar 01; 38(3):516-8. PubMed ID: 21159830
    [Abstract] [Full Text] [Related]

  • 12. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y, Gezer HH, Duruöz MT.
    Rheumatol Int; 2022 Jan 01; 42(1):81-86. PubMed ID: 34550430
    [Abstract] [Full Text] [Related]

  • 13. Canakinumab treatment in children with familial Mediterranean fever: report from a single center.
    Yazılıtaş F, Aydoğ Ö, Özlü SG, Çakıcı EK, Güngör T, Eroğlu FK, Gür G, Bülbül M.
    Rheumatol Int; 2018 May 01; 38(5):879-885. PubMed ID: 29450637
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
    Gül A.
    Best Pract Res Clin Rheumatol; 2016 Apr 01; 30(2):296-303. PubMed ID: 27886801
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of anti-interleukin-1 in children with colchicine-resistant familial Mediterranean fever.
    Erkilet HK, Gezgin Yildirim D, Esmeray P, Söylemezoğlu O.
    Pediatr Int; 2023 Apr 01; 65(1):e15588. PubMed ID: 37658625
    [Abstract] [Full Text] [Related]

  • 19. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S, Dogantan S, Edeer Karaca N, Aksu G, Kutukculer N.
    Rheumatol Int; 2020 Jan 01; 40(1):161-168. PubMed ID: 31273456
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.